SlideShare a Scribd company logo
Drug schedules
• Therapeutic goods in the United States are
regulated by the U.S. Food and Drug
Administration (FDA), which makes some
drugs available over the counter at retail
outlets and others by prescription only.
Each of the controlled substances is identified
under one of five Controlled Substances
Schedules.
■ Schedule I
■ Schedule II
■ Schedule III
■ Schedule IV
■ Schedule V
• Schedule I Drugs –
• High potential for abuse.
• No accepted medical use in the U.S. or lacks
accepted safety for use in treatment in the U.S.
• –May be used for research purposes by
properly registered individuals.
• Examples: heroin, methylene
dioxymethamphetamine, lysergic acid
diethylamide, mescaline, and all salts and
isomers thereof
 Schedule II Drugs
 High potential for abuse.
 Has a currently accepted medical use in the
U.S.
 Abuse of substance may lead to severe
psychological or physical dependence.
 Examples: morphine, oxycodone, fentanyl,
meperidine, dextroamphetamine, cocaine,
amobarbital
• Schedule III Drugs
• Abuse potential less than substances in
schedule I or schedule
• Has a currently accepted medical use in the
U.S.
• Abuse of substance may lead to moderate to
low physical dependence or high psychological
dependence.
• Examples: anabolic steroids, nalorphine,
ketamine, certain schedule II substances in
suppositories, mixtures, or limited amounts per
dosage unit
 Schedule IV Drugs –
 Abuse potential less than substances in
schedule III.
 Has a currently accepted medical use in the
U.S.
 Abuse of substance may lead to limited
physical or psychological dependence relative
to substances in schedule III.
 Examples: alprazolam, phenobarbital,
meprobamate, modafinil
INDIAN SCHEDULES:
• Schedule A
• Gives the specimens of prescribed forms necessary for obtaining
licenses, permits, certificates, intimations and so on.
• FORM 2A- Certificate of test or analysis from the Pharmacopoeial
Laboratory for Indian Medicine or Government Analyst
• FORMS 3-7- (Omitted)
• FORM 8 -Application for licence to import drugs –biological and
other special products (excluding those specified in Schedule X) to
the Drugs and Cosmetics Rules, 1945
• FORM 9 - Form of undertaking to accompany an application for
an import license
• FORM 46- Permission / Approval for manufacture of new drug
formulation
• ■There are in total upto 50 forms.
Schedule B
• This Schedule includes fees for test or analysis by the
Central Drug Laboratory or the Government Analyst.
1. Fees for test and assay of Drugs requiring use of
animals – Eg:- Adrenocorticotrophic hormone assay-
1000 Rs
2. Microbiological tests and assays – Eg:- Microbiological
assay of vitamins - 300 Rs
Schedule B(1)
Fees for the test or analysis by the Pharmacopoeial
Laboratory for Indian Medicine (PLIM) or the
Government analyst
Eg:- Determination of lethal does LD 50 to 10 on mice –
2500 Rupee
• Schedule C:-
• Includes biological and special products such as
Sera, Vaccines, Antigens,Toxin, Antitoxin, Insulin,
Bacteriophages, solution of serum proteins
intended for injection, etc.
• Schedule C1:-
• Includes Other Special products such as Digitalis
Preparations, fish liver oil, ergot preparations,
Liver extract, vitamins, hormones, etc.
■Labelled with the words-- „Caution: It is dangerous
to take this preparation except under medical
supervision‟.
■ Prohibition of import of these products after expiry
of potency
Schedule D
• Provides extent and conditions of exemption regarding
import of drugs.
Eg:- Class of drugs which are substances not intended for
medicinal use
• If the substance is imported in bulk, the importer should
certify that the substance is imported for non-medicinal
uses, and
• If imported otherwise than in bulk, each container should
bear a label indicating that the substance is not intended for
medicinal use or is intended for some purposes other than
medicinal use.
• E.g. Skimmed milk, powdered milk fortified with vitamins,
Lactose, cereal products, oats, ginger, pepper, cummins, etc.
come under this class of drugs.
• Shedule DI- permission for manufacture and DII-
permission for import.
• Schedule E
Omitted as per GOI Notification
• Schedule E (I):-
List of poisonous substances under the Ayurvedic
(including Siddha) and Unani Systems of
Medicine : Ayurvedic System:-
■ Drugs of Vegetable origin :- Bhang, Dhatura,
Jaiphala, etc
■ Drugs of Animal origin :- Snake Poison
■ Drugs of Mineral origin :- Hartala (arsenic),
Parada (mercury), etc.
Schedule F
 It includes requirements for the Functioning
and operation of a blood bank and / or for
preparation of blood components.
 General :- Blood bank location, infrastructure
requirements, Staff and equipments required,
etc.
 Minimum requirement for grant of license to
procure blood components from whole human
blood.
 F (I) :- Give details of the standards of bacterial
vaccines, antisera and diagnostic antigens.
 F (II):- Standards for Surgical Dressings that
include bandage cloth, absorbent gauze, rolled
bandage,etc.
 F (III):- Standards For Umbilical Tapes like
umbilical polyester tape, cotton tape, etc.
• Schedule FF
It lays down Standards for Ophthalmic preparations.
Ophthalmic Solutions and suspensions.
1. sterile when dispensed
2. contain suitable substances to prevent the growth of
micro-organisms
3. free from foreign matter & in bottles made of either
neutral glass or soda glass.
4. Label Contains:- „Use the solution within one month
after opening the container‟.
The words „NOT FOR INJECTION‟.
WARNING:- “ Do not touch the dropper tip or other
dispensing tip to any surface since this may
contaminate solutions”.
• Schedule G
• Medicines listed as schedule G medicines carry on the
label a caution
• Caution – “it is dangerous to take this preparation
except under medical supervision”
• The Caution is conspicuously printed and surrounded
by a line within which there should be no other words.
• It is necessary to make proper bill of sale.
• Records of purchase and sale of these medicines must
be maintained for a period of 2 years.
• Eg: Aminopterin, L-Asparaginase, Bleomycin,
Busulphan, Chlorambucil, Chlorthiazide,
Glibenclamide, Hydantoin, Hydroxyurea, Insulin,
Metformin, etc.
• Schedule H
• This Schedule includes PRESCRIPTION DRUGS i.e.
Drugs and Medicines which must be sold by retail only
when a prescription by RMP is produced.
• The time and date of prescription must be noted.
• The drug label must display the texts "Rx" and
"Schedule H drug.
• Warning : To be sold by retail on the prescription of a
Registered Medical practitioner only" prominently.
• Drugs specified in Schedule H, and comes within
{Narcotic Drugs and Psychotropic Substances Act,
1985} labelled with the symbol “NRx” & Schedule H
drug Warning prominently.
• Eg:-Abxicimab, Acyclovir, Diclofenac, Baclofen,
Carbidopa, Terazosin, etc.
• Schedule H1
• Introduced under the Drugs and Cosmetics (4th
amendment ) rules 2013, to regulate sale of antibiotics.
• To have separate regulation to check unauthorized sale
of antibiotics, thus monitoring use and abuse of these
antibiotics.
• Here, the drug has to be labelled with symbol “Rx” in
red and conspicuously displayed on left corner of the
label with the following words in box with red border
• Warning 1. It is dangerous to take this preparation
except in accordance with the medical advice.
• 2 Not to be sold by retail without the prescription of a
RMP.
• Eg:-Gemifloxacin, Cefixime, Levofloxacin,
Cefpodoxime, Clofazimine, Zolpidem, etc
• Schedule I
• Particulars as to proportion of poison in certain
cases.
• Omitted by GOI Notification .
Schedule J
• Contains a list of various diseases and conditions
which a drug may not purport to prevent or cure
or make claims to prevent or cure.
• No drug may legally claim to treat these diseases.
Eg :-AIDS, Blindness, Deafness, Encephalitis,
Diabetes, Leukemia, Paralysis, etc.
Schedule- K
• Drugs exempted from certain provisions relating to the
manufacture and sale of drugs
• Currently, non drug-licensed stores (e.g. non-
pharmacists) can sell a few medicines classified as
„Household Remedies‟ listed in Schedule K.
• Eg- Paracetamol tablets, Analgesic Balms, Antacid
Preparations, Calcium preparations with or
without Vitamin D, Gripe Water for use of infants,
Inhalers (containing drugs for treatment of cold
and nasal congestion), Syrups lozenges, pills and
tablets for cough, cold or sore throat.
• Schedule L :-
• Omitted Schedule L
• Good Laboratory Practices and requirements of
premises and equipments, Chemicals & Reagents,
etc.
Schedule M
This Schedule includes Good Manufacturing Practices
and requirements of premises, plant and
equipment for manufacture of pharmaceutical
products.
■ Part 1 :-Good Manufacturing Practices for premises
and materials.
 Part 2 :- Requirements of Plant and equipments
 M- I:- Prescribes in detail requirements of
factory premises for the manufacture of
Homeopathic drugs.
 M- II:- Prescribes requirements of factory
premises for manufacture of cosmetics.
 M- III:- Prescribes requirements of factory
premises for manufacture of medical devices.
• Schedule N
List of minimum equipment for the efficient running of a
pharmacy
Gives directions to Pharmacies regarding:-
a) Entrance of Pharmacy
b) b) Premises
c) c) Furniture & Apparatus
d) d) General Provisions.
Schedule O
Deals with the provisions applicable to disinfectant fluids.
• Part 1:- Provisions applicable to black and white fluids
Part 2:- Provisions applicable to Other Disinfectants.
Schedule P
• It deals with life period of drug and the
conditions of the storage of drugs.
• Period in months (unless otherwise specified)
between date of manufacture and date of
expiry
• ampicillin- stable for 36 month and store in
cool place
• Schedule P1
• specifies the pack size of certain drugs
• Aspirin (Low Dose) Tablets 14 Tabs per pack.
• Schedule Q
• Gives the list of dyes, colors and pigments
permitted to be used in cosmetics and soaps.
• No drug should contain a colors other than
specified by the Bureau of Indian Standards
below :
(1) Natural Colors:- Carotene, Chlorophyll, Red
Oxide of Iron, Yellow Oxide of Iron, Titanium
Di-oxide, Black Oxide of iron
(2) Artificial Colors:-Caramel
(3) Coal Tar Colors
• Schedule R
• Standards for mechanical contraceptives.
• Eg. Cu-T, etc
• Label contain:- – The date of manufacture.
• – The date up to which the contraceptive is expected to
retain its properties.
Schedule R1
• Standards for medical devices.
The following medical device shall conform to the Indian
Standards specification laid down from time to time by the
Bureau of Indian Standards: -
1. Sterile Disposable Perfusion sets for single use only
2. Sterile Disposable Hypodermic Syringes for single use only
3. Sterile Disposable Hypodermic Needles for single use only
Schedule S
 Prescribes Standard for Cosmetics
 The following cosmetics in finished form
should conform to the specifications laid down
from time to time by the Bureau of Indian
Standards (BIS).
Skin Powders , Tooth Powder, Toothpaste
,Shaving Creams, Hair Creams.
Schedule T
 Lays down the Good Manufacturing Practices
for Ayurvedic, Siddha and Unani Medicines
 PART I:- Good manufacturing practices.
 PART II:- List of recommended machinery,
equipment and minimum manufacturing
premises required for the manufacture of
various categories of ayurvedic, siddha system
of medicines.
Schedule U & U1
• Gives the particulars to be shown in
manufacturing records.
• Gives the particulars to be recorded of raw
materials.
• Gives the particulars to be recorded in analytical
records.
• The records or registers shall be retained for a
period of 5 years for Drugs & 3 years for Cosmetics
from the date of manufacture
Schedule V
• Give details of standards for patent and
proprietary medicines.
Schedule W
 Inserted as per G.O.I in 1981 and deleted IN
2000.
 Gives the name of the drugs which shall be
marketed under generic names only.
 Its label contain the Names and quantities of
active ingredients.
• Schedule X
• Contains list of narcotic drugs and psychotropic substance.
• Have a warning mentioned on a label „Schedule X drug‟ -
Warning : to be sold on retail on prescription of a RMP only.
• The label will also have a symbol „NRx‟ in red &
conspicuously displayed on the top left corner.
• After dispending the drug the pharmacist must Stamp &
retain the prescription for 2 years.
• Maintain & record purchase & sale of the drug and
preserve it for a period of 2 years from the date of
transactions.
• All the regulations of Schedule H apply. The drugs must be
kept under lock and key.
• Examples of few drugs under schedule X :- Phencyclidine,
Secobarbital, Amobarbital, Amphetamines, Glutethimide,
Methylphenidate, etc.
Schedule Y
• This Schedule includes requirements and guidelines
for permission to import and / or manufacture of new
drugs for sale or to undertake clinical trials It include:
• Application for permission
• Clinical trial:-
 Approval for trial
 Responsibilities of sponsor, investigator, Ethics
Committee
 Phases I, II, III, IV
 Studies in special population like Geriatric, Pediatric
and Pregnant/ Nursing women
 Post Marketing Surveillance

More Related Content

What's hot

Schedule m
Schedule  m Schedule  m
Schedule m
Suvarta Maru
 
Evaluation of parenterals
Evaluation of parenteralsEvaluation of parenterals
Evaluation of parenterals
monikapawar306
 
Pharmaceutical legislation in India
Pharmaceutical legislation in IndiaPharmaceutical legislation in India
Pharmaceutical legislation in India
Ganesh Shevalkar
 
Patient counselling
Patient counsellingPatient counselling
Patient counselling
RakibulHussain1
 
Community pharmacy
Community pharmacyCommunity pharmacy
Community pharmacy
KARTHIKA K.J
 
Hospital formulary
Hospital formularyHospital formulary
Hospital formulary
APOLLO JAMES
 
Pharmaceutical legislation
Pharmaceutical legislationPharmaceutical legislation
Pharmaceutical legislation
Chandrika Mourya
 
National pharmaceutical pricing athourity (nppa)
National pharmaceutical pricing athourity (nppa)National pharmaceutical pricing athourity (nppa)
National pharmaceutical pricing athourity (nppa)bdvfgbdhg
 
Forensic Pharmacy, Forensic Pharmacist and Ethics ... By Dr Duryab Jamil
Forensic Pharmacy, Forensic Pharmacist and Ethics ...   By Dr Duryab JamilForensic Pharmacy, Forensic Pharmacist and Ethics ...   By Dr Duryab Jamil
Forensic Pharmacy, Forensic Pharmacist and Ethics ... By Dr Duryab Jamil
Dr. DURYAB
 
Code of Pharmaceutical Ethics
Code of Pharmaceutical EthicsCode of Pharmaceutical Ethics
Code of Pharmaceutical Ethics
Ganesh Shevalkar
 
Quality control & evaluation of aerosol
Quality control & evaluation of aerosolQuality control & evaluation of aerosol
Quality control & evaluation of aerosolMahesh Thube Patil
 
The Drugs and Cosmetics Act and Rules
The Drugs and Cosmetics Act and RulesThe Drugs and Cosmetics Act and Rules
The Drugs and Cosmetics Act and Rules
Jobin Kunjumon Vilapurathuu
 
QUALITY CONTROL OF CAPSULES
QUALITY CONTROL OF CAPSULESQUALITY CONTROL OF CAPSULES
QUALITY CONTROL OF CAPSULES
Ramya priya
 
Hospital formulary
Hospital formularyHospital formulary
Hospital formulary
KRUSHNA ZAMBARE
 
Pharmacy and therapeutic committee(PTC)
Pharmacy and therapeutic committee(PTC)Pharmacy and therapeutic committee(PTC)
Pharmacy and therapeutic committee(PTC)
faysalahmed35
 
pharmacopoeial standards for tablet
pharmacopoeial standards for tablet pharmacopoeial standards for tablet
pharmacopoeial standards for tablet
Rohit K.
 
Parentrals
ParentralsParentrals
Parentrals
Pallavi Kurra
 
Import of drugs and cosmetic
Import of drugs and cosmeticImport of drugs and cosmetic
Import of drugs and cosmetic
Abhishek Karn
 
Central Drug Testing Laboratories & Responsibilities
Central Drug Testing Laboratories  &  Responsibilities Central Drug Testing Laboratories  &  Responsibilities
Central Drug Testing Laboratories & Responsibilities
Raghavendra institute of pharmaceutical education and research .
 

What's hot (20)

Schedule m
Schedule  m Schedule  m
Schedule m
 
Evaluation of parenterals
Evaluation of parenteralsEvaluation of parenterals
Evaluation of parenterals
 
Pharmaceutical legislation in India
Pharmaceutical legislation in IndiaPharmaceutical legislation in India
Pharmaceutical legislation in India
 
Patient counselling
Patient counsellingPatient counselling
Patient counselling
 
Community pharmacy
Community pharmacyCommunity pharmacy
Community pharmacy
 
Hospital formulary
Hospital formularyHospital formulary
Hospital formulary
 
Pharmaceutical legislation
Pharmaceutical legislationPharmaceutical legislation
Pharmaceutical legislation
 
National pharmaceutical pricing athourity (nppa)
National pharmaceutical pricing athourity (nppa)National pharmaceutical pricing athourity (nppa)
National pharmaceutical pricing athourity (nppa)
 
Tablets
TabletsTablets
Tablets
 
Forensic Pharmacy, Forensic Pharmacist and Ethics ... By Dr Duryab Jamil
Forensic Pharmacy, Forensic Pharmacist and Ethics ...   By Dr Duryab JamilForensic Pharmacy, Forensic Pharmacist and Ethics ...   By Dr Duryab Jamil
Forensic Pharmacy, Forensic Pharmacist and Ethics ... By Dr Duryab Jamil
 
Code of Pharmaceutical Ethics
Code of Pharmaceutical EthicsCode of Pharmaceutical Ethics
Code of Pharmaceutical Ethics
 
Quality control & evaluation of aerosol
Quality control & evaluation of aerosolQuality control & evaluation of aerosol
Quality control & evaluation of aerosol
 
The Drugs and Cosmetics Act and Rules
The Drugs and Cosmetics Act and RulesThe Drugs and Cosmetics Act and Rules
The Drugs and Cosmetics Act and Rules
 
QUALITY CONTROL OF CAPSULES
QUALITY CONTROL OF CAPSULESQUALITY CONTROL OF CAPSULES
QUALITY CONTROL OF CAPSULES
 
Hospital formulary
Hospital formularyHospital formulary
Hospital formulary
 
Pharmacy and therapeutic committee(PTC)
Pharmacy and therapeutic committee(PTC)Pharmacy and therapeutic committee(PTC)
Pharmacy and therapeutic committee(PTC)
 
pharmacopoeial standards for tablet
pharmacopoeial standards for tablet pharmacopoeial standards for tablet
pharmacopoeial standards for tablet
 
Parentrals
ParentralsParentrals
Parentrals
 
Import of drugs and cosmetic
Import of drugs and cosmeticImport of drugs and cosmetic
Import of drugs and cosmetic
 
Central Drug Testing Laboratories & Responsibilities
Central Drug Testing Laboratories  &  Responsibilities Central Drug Testing Laboratories  &  Responsibilities
Central Drug Testing Laboratories & Responsibilities
 

Similar to Schedules of drugs

Drug regulation
Drug regulationDrug regulation
Drug regulation
VenuDDon
 
Drug regulation
Drug regulationDrug regulation
Drug regulation
VenuDDon
 
Drug regulation
Drug regulationDrug regulation
Drug regulation
VenuDDon
 
DRUG AND COSMETIC ACT,1940 AND ITS RULES 1945.pptx
DRUG AND COSMETIC ACT,1940 AND ITS RULES 1945.pptxDRUG AND COSMETIC ACT,1940 AND ITS RULES 1945.pptx
DRUG AND COSMETIC ACT,1940 AND ITS RULES 1945.pptx
PrashantKishorRokade
 
Manufacturing of drugs and cosmetics and schedule M DRA.pptx
Manufacturing of drugs and cosmetics and schedule M DRA.pptxManufacturing of drugs and cosmetics and schedule M DRA.pptx
Manufacturing of drugs and cosmetics and schedule M DRA.pptx
Diwakar Sudhakar Shukla
 
Pharmaceutical Jurisprudence (BP505T) Unit-2 Schedules and DMR.pptx
Pharmaceutical Jurisprudence (BP505T) Unit-2 Schedules and DMR.pptxPharmaceutical Jurisprudence (BP505T) Unit-2 Schedules and DMR.pptx
Pharmaceutical Jurisprudence (BP505T) Unit-2 Schedules and DMR.pptx
Sagarpamu123
 
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptxMRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
Dimple Marathe
 
Drugs and cosmetics act, 1940 and rules
Drugs and cosmetics act, 1940 and rulesDrugs and cosmetics act, 1940 and rules
Drugs and cosmetics act, 1940 and rules
Ravish Yadav
 
35 Tips to help you Pass the 2020 PTCB Exam
35 Tips to help you Pass the 2020 PTCB Exam35 Tips to help you Pass the 2020 PTCB Exam
35 Tips to help you Pass the 2020 PTCB Exam
RxTechExam
 
Drugs & Cosmetics Act 1940 Part IV
Drugs & Cosmetics Act 1940 Part IVDrugs & Cosmetics Act 1940 Part IV
Drugs & Cosmetics Act 1940 Part IV
Pranay Sethiya
 
Community pharmacy sjk
Community pharmacy sjkCommunity pharmacy sjk
Community pharmacy sjk
shailajakamble3
 
Drugs and cosmetics act 1940 and rules 1945 swa
Drugs and cosmetics act 1940 and rules 1945 swaDrugs and cosmetics act 1940 and rules 1945 swa
Drugs and cosmetics act 1940 and rules 1945 swa
Suvarta Maru
 
investigational use of drug by Mohd Rafiq.pptx
investigational use of drug by Mohd Rafiq.pptxinvestigational use of drug by Mohd Rafiq.pptx
investigational use of drug by Mohd Rafiq.pptx
Pharmacy
 
Pharmaceuticals Schedules & Prescription drugs convention for Telemedicine
Pharmaceuticals Schedules & Prescription drugs convention for TelemedicinePharmaceuticals Schedules & Prescription drugs convention for Telemedicine
Pharmaceuticals Schedules & Prescription drugs convention for Telemedicine
Dr Pankaj Kumar Gupta
 
Drug Regulatory Systems in India
Drug Regulatory Systems in IndiaDrug Regulatory Systems in India
Drug Regulatory Systems in India
Chandra Mohan
 
Labeling of Drugs: 21 CFR Part 201
Labeling of Drugs: 21 CFR Part 201 Labeling of Drugs: 21 CFR Part 201
Labeling of Drugs: 21 CFR Part 201
Marwah Zagzoug, PhD
 
D & C Act 1940
D & C Act 1940D & C Act 1940
D & C Act 1940
Shital Kasale
 
schedules-170306164609.pptx
schedules-170306164609.pptxschedules-170306164609.pptx
schedules-170306164609.pptx
SapnaMahant
 
The drug and cosmetic act and rules
The drug and cosmetic act and rulesThe drug and cosmetic act and rules
The drug and cosmetic act and rules
Jobin Kunjumon Vilapurathuu
 
Herbal drug regulations and standardisation
Herbal drug regulations and standardisationHerbal drug regulations and standardisation
Herbal drug regulations and standardisation
Ravish Yadav
 

Similar to Schedules of drugs (20)

Drug regulation
Drug regulationDrug regulation
Drug regulation
 
Drug regulation
Drug regulationDrug regulation
Drug regulation
 
Drug regulation
Drug regulationDrug regulation
Drug regulation
 
DRUG AND COSMETIC ACT,1940 AND ITS RULES 1945.pptx
DRUG AND COSMETIC ACT,1940 AND ITS RULES 1945.pptxDRUG AND COSMETIC ACT,1940 AND ITS RULES 1945.pptx
DRUG AND COSMETIC ACT,1940 AND ITS RULES 1945.pptx
 
Manufacturing of drugs and cosmetics and schedule M DRA.pptx
Manufacturing of drugs and cosmetics and schedule M DRA.pptxManufacturing of drugs and cosmetics and schedule M DRA.pptx
Manufacturing of drugs and cosmetics and schedule M DRA.pptx
 
Pharmaceutical Jurisprudence (BP505T) Unit-2 Schedules and DMR.pptx
Pharmaceutical Jurisprudence (BP505T) Unit-2 Schedules and DMR.pptxPharmaceutical Jurisprudence (BP505T) Unit-2 Schedules and DMR.pptx
Pharmaceutical Jurisprudence (BP505T) Unit-2 Schedules and DMR.pptx
 
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptxMRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
 
Drugs and cosmetics act, 1940 and rules
Drugs and cosmetics act, 1940 and rulesDrugs and cosmetics act, 1940 and rules
Drugs and cosmetics act, 1940 and rules
 
35 Tips to help you Pass the 2020 PTCB Exam
35 Tips to help you Pass the 2020 PTCB Exam35 Tips to help you Pass the 2020 PTCB Exam
35 Tips to help you Pass the 2020 PTCB Exam
 
Drugs & Cosmetics Act 1940 Part IV
Drugs & Cosmetics Act 1940 Part IVDrugs & Cosmetics Act 1940 Part IV
Drugs & Cosmetics Act 1940 Part IV
 
Community pharmacy sjk
Community pharmacy sjkCommunity pharmacy sjk
Community pharmacy sjk
 
Drugs and cosmetics act 1940 and rules 1945 swa
Drugs and cosmetics act 1940 and rules 1945 swaDrugs and cosmetics act 1940 and rules 1945 swa
Drugs and cosmetics act 1940 and rules 1945 swa
 
investigational use of drug by Mohd Rafiq.pptx
investigational use of drug by Mohd Rafiq.pptxinvestigational use of drug by Mohd Rafiq.pptx
investigational use of drug by Mohd Rafiq.pptx
 
Pharmaceuticals Schedules & Prescription drugs convention for Telemedicine
Pharmaceuticals Schedules & Prescription drugs convention for TelemedicinePharmaceuticals Schedules & Prescription drugs convention for Telemedicine
Pharmaceuticals Schedules & Prescription drugs convention for Telemedicine
 
Drug Regulatory Systems in India
Drug Regulatory Systems in IndiaDrug Regulatory Systems in India
Drug Regulatory Systems in India
 
Labeling of Drugs: 21 CFR Part 201
Labeling of Drugs: 21 CFR Part 201 Labeling of Drugs: 21 CFR Part 201
Labeling of Drugs: 21 CFR Part 201
 
D & C Act 1940
D & C Act 1940D & C Act 1940
D & C Act 1940
 
schedules-170306164609.pptx
schedules-170306164609.pptxschedules-170306164609.pptx
schedules-170306164609.pptx
 
The drug and cosmetic act and rules
The drug and cosmetic act and rulesThe drug and cosmetic act and rules
The drug and cosmetic act and rules
 
Herbal drug regulations and standardisation
Herbal drug regulations and standardisationHerbal drug regulations and standardisation
Herbal drug regulations and standardisation
 

More from Suvarta Maru

case study - Urinary tract infection with diabetes mellitus
case study - Urinary tract infection with  diabetes mellitus case study - Urinary tract infection with  diabetes mellitus
case study - Urinary tract infection with diabetes mellitus
Suvarta Maru
 
WORLD HEALTH ORGANIZATION ( WHO )
WORLD HEALTH ORGANIZATION ( WHO )WORLD HEALTH ORGANIZATION ( WHO )
WORLD HEALTH ORGANIZATION ( WHO )
Suvarta Maru
 
Various approachesto drug discovery
Various approachesto drug discoveryVarious approachesto drug discovery
Various approachesto drug discovery
Suvarta Maru
 
USFDA & WHO
USFDA & WHOUSFDA & WHO
USFDA & WHO
Suvarta Maru
 
US FDA
US FDA US FDA
US FDA
Suvarta Maru
 
Toxicity slides
Toxicity slidesToxicity slides
Toxicity slides
Suvarta Maru
 
TGA & MHRA
TGA & MHRATGA & MHRA
TGA & MHRA
Suvarta Maru
 
Thermal analysis
Thermal analysisThermal analysis
Thermal analysis
Suvarta Maru
 
Stroke study
Stroke studyStroke study
Stroke study
Suvarta Maru
 
Quinolone antibacterials
Quinolone antibacterialsQuinolone antibacterials
Quinolone antibacterials
Suvarta Maru
 
Protein binding of drug
Protein binding of drugProtein binding of drug
Protein binding of drug
Suvarta Maru
 
Preclinical trials
Preclinical trialsPreclinical trials
Preclinical trials
Suvarta Maru
 
Poison AND treatment
Poison AND treatmentPoison AND treatment
Poison AND treatment
Suvarta Maru
 
Pharmacovigilance STUDY
Pharmacovigilance STUDYPharmacovigilance STUDY
Pharmacovigilance STUDY
Suvarta Maru
 
Pharmacoeconomics STUDY
Pharmacoeconomics STUDYPharmacoeconomics STUDY
Pharmacoeconomics STUDY
Suvarta Maru
 
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
Suvarta Maru
 
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
Suvarta Maru
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kinetics
Suvarta Maru
 
New drug approval
New drug approvalNew drug approval
New drug approval
Suvarta Maru
 
NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)
Suvarta Maru
 

More from Suvarta Maru (20)

case study - Urinary tract infection with diabetes mellitus
case study - Urinary tract infection with  diabetes mellitus case study - Urinary tract infection with  diabetes mellitus
case study - Urinary tract infection with diabetes mellitus
 
WORLD HEALTH ORGANIZATION ( WHO )
WORLD HEALTH ORGANIZATION ( WHO )WORLD HEALTH ORGANIZATION ( WHO )
WORLD HEALTH ORGANIZATION ( WHO )
 
Various approachesto drug discovery
Various approachesto drug discoveryVarious approachesto drug discovery
Various approachesto drug discovery
 
USFDA & WHO
USFDA & WHOUSFDA & WHO
USFDA & WHO
 
US FDA
US FDA US FDA
US FDA
 
Toxicity slides
Toxicity slidesToxicity slides
Toxicity slides
 
TGA & MHRA
TGA & MHRATGA & MHRA
TGA & MHRA
 
Thermal analysis
Thermal analysisThermal analysis
Thermal analysis
 
Stroke study
Stroke studyStroke study
Stroke study
 
Quinolone antibacterials
Quinolone antibacterialsQuinolone antibacterials
Quinolone antibacterials
 
Protein binding of drug
Protein binding of drugProtein binding of drug
Protein binding of drug
 
Preclinical trials
Preclinical trialsPreclinical trials
Preclinical trials
 
Poison AND treatment
Poison AND treatmentPoison AND treatment
Poison AND treatment
 
Pharmacovigilance STUDY
Pharmacovigilance STUDYPharmacovigilance STUDY
Pharmacovigilance STUDY
 
Pharmacoeconomics STUDY
Pharmacoeconomics STUDYPharmacoeconomics STUDY
Pharmacoeconomics STUDY
 
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
OPTICAL ROTATORY DISPERSION & CIRCULAR DICHORISM(ORD CD)
 
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
NON STEROIDAL ANTI INFLAMMTORY DRUGS ( NSAID'S)
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kinetics
 
New drug approval
New drug approvalNew drug approval
New drug approval
 
NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)
 

Recently uploaded

The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Po-Chuan Chen
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
EverAndrsGuerraGuerr
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 

Recently uploaded (20)

The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
 
Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
Thesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.pptThesis Statement for students diagnonsed withADHD.ppt
Thesis Statement for students diagnonsed withADHD.ppt
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 

Schedules of drugs

  • 2. • Therapeutic goods in the United States are regulated by the U.S. Food and Drug Administration (FDA), which makes some drugs available over the counter at retail outlets and others by prescription only. Each of the controlled substances is identified under one of five Controlled Substances Schedules. ■ Schedule I ■ Schedule II ■ Schedule III ■ Schedule IV ■ Schedule V
  • 3. • Schedule I Drugs – • High potential for abuse. • No accepted medical use in the U.S. or lacks accepted safety for use in treatment in the U.S. • –May be used for research purposes by properly registered individuals. • Examples: heroin, methylene dioxymethamphetamine, lysergic acid diethylamide, mescaline, and all salts and isomers thereof
  • 4.  Schedule II Drugs  High potential for abuse.  Has a currently accepted medical use in the U.S.  Abuse of substance may lead to severe psychological or physical dependence.  Examples: morphine, oxycodone, fentanyl, meperidine, dextroamphetamine, cocaine, amobarbital
  • 5. • Schedule III Drugs • Abuse potential less than substances in schedule I or schedule • Has a currently accepted medical use in the U.S. • Abuse of substance may lead to moderate to low physical dependence or high psychological dependence. • Examples: anabolic steroids, nalorphine, ketamine, certain schedule II substances in suppositories, mixtures, or limited amounts per dosage unit
  • 6.  Schedule IV Drugs –  Abuse potential less than substances in schedule III.  Has a currently accepted medical use in the U.S.  Abuse of substance may lead to limited physical or psychological dependence relative to substances in schedule III.  Examples: alprazolam, phenobarbital, meprobamate, modafinil
  • 7. INDIAN SCHEDULES: • Schedule A • Gives the specimens of prescribed forms necessary for obtaining licenses, permits, certificates, intimations and so on. • FORM 2A- Certificate of test or analysis from the Pharmacopoeial Laboratory for Indian Medicine or Government Analyst • FORMS 3-7- (Omitted) • FORM 8 -Application for licence to import drugs –biological and other special products (excluding those specified in Schedule X) to the Drugs and Cosmetics Rules, 1945 • FORM 9 - Form of undertaking to accompany an application for an import license • FORM 46- Permission / Approval for manufacture of new drug formulation • ■There are in total upto 50 forms.
  • 8. Schedule B • This Schedule includes fees for test or analysis by the Central Drug Laboratory or the Government Analyst. 1. Fees for test and assay of Drugs requiring use of animals – Eg:- Adrenocorticotrophic hormone assay- 1000 Rs 2. Microbiological tests and assays – Eg:- Microbiological assay of vitamins - 300 Rs Schedule B(1) Fees for the test or analysis by the Pharmacopoeial Laboratory for Indian Medicine (PLIM) or the Government analyst Eg:- Determination of lethal does LD 50 to 10 on mice – 2500 Rupee
  • 9. • Schedule C:- • Includes biological and special products such as Sera, Vaccines, Antigens,Toxin, Antitoxin, Insulin, Bacteriophages, solution of serum proteins intended for injection, etc. • Schedule C1:- • Includes Other Special products such as Digitalis Preparations, fish liver oil, ergot preparations, Liver extract, vitamins, hormones, etc. ■Labelled with the words-- „Caution: It is dangerous to take this preparation except under medical supervision‟. ■ Prohibition of import of these products after expiry of potency
  • 10. Schedule D • Provides extent and conditions of exemption regarding import of drugs. Eg:- Class of drugs which are substances not intended for medicinal use • If the substance is imported in bulk, the importer should certify that the substance is imported for non-medicinal uses, and • If imported otherwise than in bulk, each container should bear a label indicating that the substance is not intended for medicinal use or is intended for some purposes other than medicinal use. • E.g. Skimmed milk, powdered milk fortified with vitamins, Lactose, cereal products, oats, ginger, pepper, cummins, etc. come under this class of drugs. • Shedule DI- permission for manufacture and DII- permission for import.
  • 11. • Schedule E Omitted as per GOI Notification • Schedule E (I):- List of poisonous substances under the Ayurvedic (including Siddha) and Unani Systems of Medicine : Ayurvedic System:- ■ Drugs of Vegetable origin :- Bhang, Dhatura, Jaiphala, etc ■ Drugs of Animal origin :- Snake Poison ■ Drugs of Mineral origin :- Hartala (arsenic), Parada (mercury), etc.
  • 12. Schedule F  It includes requirements for the Functioning and operation of a blood bank and / or for preparation of blood components.  General :- Blood bank location, infrastructure requirements, Staff and equipments required, etc.  Minimum requirement for grant of license to procure blood components from whole human blood.
  • 13.  F (I) :- Give details of the standards of bacterial vaccines, antisera and diagnostic antigens.  F (II):- Standards for Surgical Dressings that include bandage cloth, absorbent gauze, rolled bandage,etc.  F (III):- Standards For Umbilical Tapes like umbilical polyester tape, cotton tape, etc.
  • 14. • Schedule FF It lays down Standards for Ophthalmic preparations. Ophthalmic Solutions and suspensions. 1. sterile when dispensed 2. contain suitable substances to prevent the growth of micro-organisms 3. free from foreign matter & in bottles made of either neutral glass or soda glass. 4. Label Contains:- „Use the solution within one month after opening the container‟. The words „NOT FOR INJECTION‟. WARNING:- “ Do not touch the dropper tip or other dispensing tip to any surface since this may contaminate solutions”.
  • 15. • Schedule G • Medicines listed as schedule G medicines carry on the label a caution • Caution – “it is dangerous to take this preparation except under medical supervision” • The Caution is conspicuously printed and surrounded by a line within which there should be no other words. • It is necessary to make proper bill of sale. • Records of purchase and sale of these medicines must be maintained for a period of 2 years. • Eg: Aminopterin, L-Asparaginase, Bleomycin, Busulphan, Chlorambucil, Chlorthiazide, Glibenclamide, Hydantoin, Hydroxyurea, Insulin, Metformin, etc.
  • 16. • Schedule H • This Schedule includes PRESCRIPTION DRUGS i.e. Drugs and Medicines which must be sold by retail only when a prescription by RMP is produced. • The time and date of prescription must be noted. • The drug label must display the texts "Rx" and "Schedule H drug. • Warning : To be sold by retail on the prescription of a Registered Medical practitioner only" prominently. • Drugs specified in Schedule H, and comes within {Narcotic Drugs and Psychotropic Substances Act, 1985} labelled with the symbol “NRx” & Schedule H drug Warning prominently. • Eg:-Abxicimab, Acyclovir, Diclofenac, Baclofen, Carbidopa, Terazosin, etc.
  • 17. • Schedule H1 • Introduced under the Drugs and Cosmetics (4th amendment ) rules 2013, to regulate sale of antibiotics. • To have separate regulation to check unauthorized sale of antibiotics, thus monitoring use and abuse of these antibiotics. • Here, the drug has to be labelled with symbol “Rx” in red and conspicuously displayed on left corner of the label with the following words in box with red border • Warning 1. It is dangerous to take this preparation except in accordance with the medical advice. • 2 Not to be sold by retail without the prescription of a RMP. • Eg:-Gemifloxacin, Cefixime, Levofloxacin, Cefpodoxime, Clofazimine, Zolpidem, etc
  • 18. • Schedule I • Particulars as to proportion of poison in certain cases. • Omitted by GOI Notification . Schedule J • Contains a list of various diseases and conditions which a drug may not purport to prevent or cure or make claims to prevent or cure. • No drug may legally claim to treat these diseases. Eg :-AIDS, Blindness, Deafness, Encephalitis, Diabetes, Leukemia, Paralysis, etc.
  • 19. Schedule- K • Drugs exempted from certain provisions relating to the manufacture and sale of drugs • Currently, non drug-licensed stores (e.g. non- pharmacists) can sell a few medicines classified as „Household Remedies‟ listed in Schedule K. • Eg- Paracetamol tablets, Analgesic Balms, Antacid Preparations, Calcium preparations with or without Vitamin D, Gripe Water for use of infants, Inhalers (containing drugs for treatment of cold and nasal congestion), Syrups lozenges, pills and tablets for cough, cold or sore throat.
  • 20. • Schedule L :- • Omitted Schedule L • Good Laboratory Practices and requirements of premises and equipments, Chemicals & Reagents, etc. Schedule M This Schedule includes Good Manufacturing Practices and requirements of premises, plant and equipment for manufacture of pharmaceutical products. ■ Part 1 :-Good Manufacturing Practices for premises and materials.  Part 2 :- Requirements of Plant and equipments
  • 21.  M- I:- Prescribes in detail requirements of factory premises for the manufacture of Homeopathic drugs.  M- II:- Prescribes requirements of factory premises for manufacture of cosmetics.  M- III:- Prescribes requirements of factory premises for manufacture of medical devices.
  • 22. • Schedule N List of minimum equipment for the efficient running of a pharmacy Gives directions to Pharmacies regarding:- a) Entrance of Pharmacy b) b) Premises c) c) Furniture & Apparatus d) d) General Provisions. Schedule O Deals with the provisions applicable to disinfectant fluids. • Part 1:- Provisions applicable to black and white fluids Part 2:- Provisions applicable to Other Disinfectants.
  • 23. Schedule P • It deals with life period of drug and the conditions of the storage of drugs. • Period in months (unless otherwise specified) between date of manufacture and date of expiry • ampicillin- stable for 36 month and store in cool place • Schedule P1 • specifies the pack size of certain drugs • Aspirin (Low Dose) Tablets 14 Tabs per pack.
  • 24. • Schedule Q • Gives the list of dyes, colors and pigments permitted to be used in cosmetics and soaps. • No drug should contain a colors other than specified by the Bureau of Indian Standards below : (1) Natural Colors:- Carotene, Chlorophyll, Red Oxide of Iron, Yellow Oxide of Iron, Titanium Di-oxide, Black Oxide of iron (2) Artificial Colors:-Caramel (3) Coal Tar Colors
  • 25. • Schedule R • Standards for mechanical contraceptives. • Eg. Cu-T, etc • Label contain:- – The date of manufacture. • – The date up to which the contraceptive is expected to retain its properties. Schedule R1 • Standards for medical devices. The following medical device shall conform to the Indian Standards specification laid down from time to time by the Bureau of Indian Standards: - 1. Sterile Disposable Perfusion sets for single use only 2. Sterile Disposable Hypodermic Syringes for single use only 3. Sterile Disposable Hypodermic Needles for single use only
  • 26. Schedule S  Prescribes Standard for Cosmetics  The following cosmetics in finished form should conform to the specifications laid down from time to time by the Bureau of Indian Standards (BIS). Skin Powders , Tooth Powder, Toothpaste ,Shaving Creams, Hair Creams.
  • 27. Schedule T  Lays down the Good Manufacturing Practices for Ayurvedic, Siddha and Unani Medicines  PART I:- Good manufacturing practices.  PART II:- List of recommended machinery, equipment and minimum manufacturing premises required for the manufacture of various categories of ayurvedic, siddha system of medicines.
  • 28. Schedule U & U1 • Gives the particulars to be shown in manufacturing records. • Gives the particulars to be recorded of raw materials. • Gives the particulars to be recorded in analytical records. • The records or registers shall be retained for a period of 5 years for Drugs & 3 years for Cosmetics from the date of manufacture Schedule V • Give details of standards for patent and proprietary medicines.
  • 29. Schedule W  Inserted as per G.O.I in 1981 and deleted IN 2000.  Gives the name of the drugs which shall be marketed under generic names only.  Its label contain the Names and quantities of active ingredients.
  • 30. • Schedule X • Contains list of narcotic drugs and psychotropic substance. • Have a warning mentioned on a label „Schedule X drug‟ - Warning : to be sold on retail on prescription of a RMP only. • The label will also have a symbol „NRx‟ in red & conspicuously displayed on the top left corner. • After dispending the drug the pharmacist must Stamp & retain the prescription for 2 years. • Maintain & record purchase & sale of the drug and preserve it for a period of 2 years from the date of transactions. • All the regulations of Schedule H apply. The drugs must be kept under lock and key. • Examples of few drugs under schedule X :- Phencyclidine, Secobarbital, Amobarbital, Amphetamines, Glutethimide, Methylphenidate, etc.
  • 31. Schedule Y • This Schedule includes requirements and guidelines for permission to import and / or manufacture of new drugs for sale or to undertake clinical trials It include: • Application for permission • Clinical trial:-  Approval for trial  Responsibilities of sponsor, investigator, Ethics Committee  Phases I, II, III, IV  Studies in special population like Geriatric, Pediatric and Pregnant/ Nursing women  Post Marketing Surveillance